Rapacuronium
- Level
- Commodity
- Parent
- 51152000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51152010This classification denotes a muscle relaxant with the molecular formula C37H61N2O4.Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 65Q4QDG4KC, chemically known as piperidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-3-(acetyloxy)-17-(1-oxopropoxy)-2-(1-piperidinyl)androstan-16-yl)-1-(2-propenyl)-, bromide but generally known as rapacuronium bromide, which bears US NIH Compound Identifier 177969. European Medicines Agency schedules Rapacuronium bromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10260MIG. The term RAPACURONIUM BROMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). As of Q4 2014, RAPACURONIUM remains the US FDA Preferred Term for this commodity. SMILES: CCC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)OC(=O)C)N5CCCCC5)C)C)[N+]6(CCCCC6)CC=C.[Br-].
Same parent
Under 51152000 · 74Activities that produce or sell this
KBLI · 8Inherited from family 51150000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.